| Date Filed | Type | Description |
| 08/01/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Disposed/sold 120,000 shares
@ $0 |
|
| 12/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/03/2021 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 200,000 shares
@ $0
Granted 150,000 options to buy
@ $3.25, valued at
$487.5k
|
|
| 11/18/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 7,760 shares
@ $2.17, valued at
$16.8k
|
|
| 06/15/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Bought 8,500 shares
@ $3.14, valued at
$26.7k
|
|
| 06/08/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 42,810 shares
@ $3.31, valued at
$141.7k
|
|
| 05/26/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 42,262 shares
@ $4.99, valued at
$210.9k
|
|
| 05/08/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 8,420 shares
@ $5.24, valued at
$44.1k
|
|
| 02/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 1,648 shares
@ $6, valued at
$9.9k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/04/2019 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Sold 10,000 shares
@ $7.16, valued at
$71.6k
|
|
| 11/26/2019 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 10,102 shares
@ $6.22, valued at
$62.8k
|
|
| 11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/26/2019 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,558 shares
@ $5.13, valued at
$8k
|
|
| 06/12/2019 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 10,185 shares
@ $6.36, valued at
$64.8k
|
|
| 04/03/2019 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Paid exercise price by delivering 1,292 shares
@ $3.55, valued at
$4.6k
|
|
| 12/03/2018 |
4/A
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 103,500 options to buy
@ $3.45, valued at
$357.1k
|
|
| 11/29/2018 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted options to buy
@ $3.45, valued at
$0 |
|
| 07/03/2018 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 300,000 shares
@ $0
Paid exercise price by delivering 119,510 shares
@ $2.46, valued at
$294k
|
|
| 03/14/2018 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 300,000 options to buy
@ $7.29, valued at
$2.2M
|
|
| 01/18/2018 |
4
| File Justin J. (CFO) has filed a Form 4 on Evofem Biosciences, Inc.|
Txns:
| Granted 12,833 options to buy
@ $46.36, valued at
$594.9k
Granted 10,266 options to buy
@ $46.36, valued at
$475.9k
|
|
| 01/18/2018 |
3
| File Justin J. (CFO) has filed a Form 3 on Evofem Biosciences, Inc. |